Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 25CNS 3Genitourinary 1Gastrointestinal 1

Conditions

Wilms Tumor 16Kidney Neoplasms 7Sarcoma 3Neuroblastoma 3Neoplasms 3Osteosarcoma 2Lymphoma 2Leukemia 2Carcinoma, Renal Cell 2Bone Neoplasms 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Hepatoblastoma 1Hematologic Neoplasms 1Endodermal Sinus Tumor 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Embryonal 1Brain Neoplasms 1Beckwith-Wiedemann Syndrome 1Askin Tumor 1

Interventions

X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Nuclear Medicine Department, Hospital 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Busulfan 4Filgrastim 3Cyclophosphamide 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fludarabine 2ensartinib 2cabozantinib 2Vemurafenib 2Topotecan 2Thiotepa 2Temozolomide 2Stem Cell Transplantation 2Sirolimus 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × Vincristine × Genitourinary × Clear all
NCT02085148 2024-04-22

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Bayer

Phase 1 Completed
62 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡